Not a good buy right now: price is stretched short-term (RSI extremely overbought) and sitting just below near-term resistance, which limits upside for an impatient entry.
Options positioning is bullish (very low put/call ratios), but absolute volume is light, so it’s not a strong confirmatory “risk-on” signal.
With no proprietary Intellectia buy signals today and a recent Street Sell stance with a $35 target, the risk/reward at ~$35 looks unfavorable for immediate buying.
Technical Analysis
Trend/momentum: MACD histogram is positive (0.212) and expanding, indicating bullish momentum is still present.
Overbought: RSI(6)=84.89 signals an overbought condition; near-term pullback risk is elevated.
Moving averages: Converging MAs suggest the move may be losing trend clarity and could consolidate.
Levels: Pivot 34.299 is the key “line in the sand.” Immediate resistance at R1=35.541 (close overhead); next resistance R2=36.307. Supports at S1=33.057 and S2=32.291.
Pattern-based forward look (provided): 80% chance of ~-0.38% next day and ~-1.45% next month, which argues against chasing strength.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Put/call ratios are very low (OI PCR 0.23; Volume PCR 0.13) → bullish/skewed toward calls.
Activity: Today’s total option volume is only 26 contracts (calls 23 vs puts 3), far below 5D/10D average volumes (252/189), so sentiment read is weakly evidenced.
Volatility: 30D IV 37.74 vs historical vol 16.45 → options are pricing relatively high implied move vs realized; IV percentile ~50 is mid-range (not “cheap”).
Technical Summary
Sell
4
Buy
7
Positive Catalysts
Profitability quality improved: gross margin up YoY (37.87%, +0.85% YoY) and net income up slightly.
Momentum remains bullish by MACD, which can support follow-through if price clears ~35.54 convincingly.
Net income $46.364M, +1.59% YoY (modest growth despite lower revenue).
EPS $0.49, ~flat YoY.
Gross margin 37.87%, +0.85% YoY (margin expansion is a positive trend, but growth is not accelerating).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Most recent update (2025-12-05): UBS lowered price target to $35 from $39 and reiterated a Sell rating.
Wall Street pro view (bull case): margin improvement and stable earnings can support the stock if growth re-accelerates.
Wall Street con view (bear case): limited upside at current levels with a Sell rating and reduced PT; top-line is slipping, which weakens the fundamental momentum.
Wall Street analysts forecast FIZZ stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FIZZ is 35 USD with a low forecast of 35 USD and a high forecast of 35 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast FIZZ stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FIZZ is 35 USD with a low forecast of 35 USD and a high forecast of 35 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
1 Sell
Moderate Sell
Current: 35.220
Low
35
Averages
35
High
35
Current: 35.220
Low
35
Averages
35
High
35
UBS
NULL -> Sell
downgrade
$39 -> $35
AI Analysis
2025-12-05
Reason
UBS
Price Target
$39 -> $35
AI Analysis
2025-12-05
downgrade
NULL -> Sell
Reason
UBS lowered the firm's price target on National Beverage to $35 from $39 and keeps a Sell rating on the shares ahead of the fiscal Q2 report.
UBS
Sell
downgrade
$40 -> $39
2025-09-15
Reason
UBS
Price Target
$40 -> $39
2025-09-15
downgrade
Sell
Reason
UBS lowered the firm's price target on National Beverage to $39 from $40 and keeps a Sell rating on the shares. National Beverage reported in line Q1 EPS, as weaker top line growth was offset by better than expected gross margin, the analyst tells investors in a research note. UBS continues to believe that the investment case is largely dependent on top line and market share trends, and with the tracked data indicating that volumes have continued to weaken quarter-to-date, expects that sentiment is likely to remain negative until there is greater signs that stabilization or improvement is on the horizon.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for FIZZ
